(MedPage Today) — ORLANDO — Long-term results from trials of new drugs for hereditary angioedema (HAE) continue to support efficacy and safety, researchers reported at the American College of Allergy, Asthma & Immunology meeting.
“Long…
Source link : https://www.medpagetoday.com/meetingcoverage/acaai/118441
Author :
Publish date : 2025-11-11 16:27:00
Copyright for syndicated content belongs to the linked Source.
